Literature DB >> 655539

Introduction of the ocusert ocular system to an ophthalmic practice.

R H Stewart, S Novak.   

Abstract

This study, on a sample of 81 patients, was primarily shortterm. The objectives were to determine what type of patient would be successful on the Ocusert; to see if we had similar pressure control with the Ocusert as with drops; and to see if the advantages were obvious to our patients. We found that 56% of our patients could wear the unit successfully (after 3 months of study). The major reasons for discontinuing the Ocusert were discomfort and retention, but age was also a significant factor to success. We found the most critical period of adjustment was the first 2 weeks. It was found that 46% of the group stayed in the smae pressure range, 30% moved to a lower pressure range, and 24% moved to a higher category of intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655539

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  7 in total

1.  Cervical cancer treatment with a locally insertable controlled release delivery system.

Authors:  Vandana Keskar; Prem S Mohanty; Ernest J Gemeinhart; Richard A Gemeinhart
Journal:  J Control Release       Date:  2006-08-26       Impact factor: 9.776

2.  Sustained release of a corticosteroid using polymeric implants.

Authors:  S Cawley; D J Ormrod; J W Paxton; T E Miller
Journal:  Agents Actions       Date:  1986-11

Review 3.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

4.  Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.

Authors:  Morgan V Fedorchak; Ian P Conner; Joel S Schuman; Anthony Cugini; Steven R Little
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 5.  Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Front Neurosci       Date:  2017-09-05       Impact factor: 4.677

6.  Dexamethasone implant in silicone oil: in vitro behavior.

Authors:  Erick Omar Flores-Villalobos; J Abel Ramírez-Estudillo; Atzin Robles-Contreras; Jacqueline L Oliva-Ramírez
Journal:  Int J Retina Vitreous       Date:  2018-06-20

Review 7.  Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.

Authors:  Rohan B Singh; Parul Ichhpujani; Sahil Thakur; Sumeet Jindal
Journal:  Ther Adv Ophthalmol       Date:  2020-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.